Condensed Consolidated Statements of Cash Flows (USD $) In Thousands	3 Months Ended		6 Months Ended
	Jul. 30, 2011	Jul. 31, 2010	Jul. 30, 2011	Jul. 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) earnings	$ (392)	$ (3,183)	$ 14,401	$ 5,433
Tax benefit of stock options exercised	(3,558)	0	(3,558)	0
Adjustments to reconcile net (loss) earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	13,002	11,625	25,204	23,518
Amortization of deferred note expense and debt discount	165	104	311	208
Deferred income taxes	1,531	163	318	(547)
Provision for losses on accounts receivable	435	7	676	305
Impairment of long-lived assets	313	1,934	1,060	4,290
Restricted stock and share-based compensation	1,641	2,004	3,237	3,715
Provision for discontinued operations	1,224	1,301	1,524	1,213
Other	240	626	589	972
Effect on cash from changes in working capital and other assets and liabilities:
Accounts receivable	5,085	(136)	5,498	(2,717)
Inventories	(69,738)	(79,832)	(81,804)	(84,373)
Prepaids and other current assets	(17,884)	(8,481)	(18,473)	(9,814)
Accounts payable	53,567	53,361	67,279	72,681
Other accrued liabilities	(6,018)	(3,425)	(25,746)	872
Other assets and liabilities	(9,791)	(2,397)	(8,696)	(6,183)
Net cash (used in) provided by operating activities	(30,178)	(26,329)	(18,180)	9,573
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(13,616)	(5,320)	(23,213)	(11,860)
Acquisitions, net of cash acquired	(87,402)	(11,809)	(87,402)	(15,254)
Proceeds from assets sales	23	0	23	2
Net cash used in investing activities	(100,995)	(17,129)	(110,592)	(27,112)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of capital leases	0	(19)	(21)	(60)
Payments of long-term debt	(16,074)	(1,018)	(16,074)	(1,018)
Tax benefit of stock options exercised	3,558	0	3,558	0
Shares repurchased	0	(9,616)	0	(11,691)
Change in overdraft balances	455	(2,422)	(2,823)	(3,278)
Borrowings under revolving credit facility	151,000	0	151,000	0
Payments on revolving credit facility	(33,519)	0	(33,519)	0
Dividends paid on non-redeemable preferred stock	(49)	(49)	(98)	(98)
Exercise of stock options	5,470	220	7,309	573
Deferred financing costs	(846)	0	(912)	0
Net cash provided by (used in) financing activities	109,995	(12,904)	108,420	(15,572)
Net decrease in cash and cash equivalents	(21,178)	(56,362)	(20,352)	(33,111)
Cash and cash equivalents at beginning of period	56,760	105,399	55,934	82,148
Cash and cash equivalents at end of period	35,582	49,037	35,582	49,037
Net cash paid for:
Interest	1,539	122	1,824	249
Income taxes	$ 26,439	$ 12,707	$ 38,573	$ 13,167